Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT02705651
Eligibility Criteria:
Inclusion Criteria:
* Verified MEN1 syndrome by molecular genetics (known mutation)
* Non-functioning pNET
* Largest ("leading") pancreatic tumor with ≤20 mm in diameter and (if present) one small tumor \<15 mm in diameter as reference lesion
* G1 or G2 (Ki-67 ≤ 10%) according to endoscopic ultrasound/fine-needle aspiration (EUS/FNA) acquired by 19-gauge needle
* Functional imaging: Ga68-DOTA-conjugated peptide positron emission tomography (PET) computed tomography (CT) or preferably Ga68-DOTA-conjugated peptide magnetic resonance imaging (MRI)
* Tumor(s) limited to the pancreas (N0, M0)
Exclusion Criteria:
* Functioning tumor - hormone excess
* Neuroendocrine carcinoma (G3)
* Metastatic disease (N1, M1)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02705651
Study Brief:
Protocol Section:
NCT02705651